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pulmonary function and chronic thoracic
pain after coronary artery bypass graft




Background: Coronary artery bypass graft surgery (CABG) is an effective and widespread coronary revascularisation
technique, nevertheless there are a number of long-term postoperative complications from which patients can
suffer. One year after CABG surgery pulmonary function is decreased by 12% and 30% of the patients suffer from
chronic thoracic pain. To date and to our knowledge there are no effective treatments for these conditions. The
aim of the present clinical trial is to explore the effectiveness of osteopathic treatment on these conditions.
Methods: The study is designed as a randomised controlled trial with two parallel groups. Group A will receive a
standard cardiac rehabilitation programme during 12 weeks and group B will receive the same standard cardiac
rehabilitation programme supplemented with four osteopathic treatments (OT). OT will be performed at week 4, 5,
8 and 12 after surgery. Three hundred and eight patients (Group A: n = 154, Group B: n = 154) will be enrolled from
the cardiothoracic surgery department of the Jessa Hospital Hasselt. Blinding will be assured for the staff of the
cardiac rehabilitation centre and outcome assessors. Primary outcome measure will be the mean difference in
change from baseline in slow vital capacity (SVC) at 12 weeks after surgery between groups. Secondary outcome
measures will be the change from baseline in quality of life, pain, thoracic stiffness and maximal aerobic capacity at
12 weeks after surgery. A follow-up is planned 52 weeks after surgery for SVC, quality of life, pain and thoracic
stiffness. Intention to treat analysis will be executed.
Discussion: The OstinCare study has been designed to explore the potential long-term added value of osteopathic
treatment in the management of decreased pulmonary function, chronic thoracic pain and diminished thoracic
mobility after CABG surgery.
Trial registration: The protocol has been retrospectively registered on ClinicalTrials.gov (NCT01714791).
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Background
Approximately 640,000 coronary artery bypass graft
(CABG) surgery procedures are performed in Europe
and the United States each year to restore or
optimize myocardial perfusion in coronary artery dis-
ease [1, 2]. Worldwide there are approximately over
two million open-heart surgeries per year [3]. In this
surgical intervention, venous and/or arterial grafts are
used to bypass the coronary occlusion or stenosis. Be-
cause cardioplegia (induction of temporary cardiac ar-
rest) is routinely used, the patient’s circulation is
coupled to a cardiopulmonary bypass and access to
the heart is most often achieved by median sternot-
omy. After CABG surgery, a hospital stay of 1 to
2 weeks is generally required [4, 5].
Although CABG surgery is an effective coronary
revascularisation technique, there are a number of
postoperative complications from which patients can
suffer. For example, a decrease in pulmonary function
is a frequently observed complication after CABG
surgery. During the first week after CABG surgery
vital capacity (VC) decreases by 30–60% [6–9] and
even up to 1 year this remains reduced by 12% [10, 11].
Reduced VC has a negative effect on exercise tolerance
(Vo2max) [12] and therefore it is important to optimize
pulmonary function after CABG surgery. No method of
postoperative therapy has been distinguished in treating
or preventing these long-term changes [6].
In addition, Ragnarsdòttir et al. [8] found a diminished
mobility of the left hemithorax at 3 months after CABG
surgery. This decreased thoracic mobility was still
present 12 months after surgery [11]. Thoracic mobility
and vital capacity were affected more when the left in-
ternal thoracic artery (LITA)-retractor was used and re-
duced thoracic mobility is related to a diminished
pulmonary function [10].
Chronic pain, which is defined as pain without ap-
parent biological value that has persisted beyond the
normal tissue healing time, which usually takes
3 months [13] after CABG surgery. Chronic pain after
CABG surgery is described in several studies reaching
a time period from 3 to 28 months [14–20]. Kehlet et
al. [14] reported a pain prevalence of 30–50%, from
which 5–10% suffer from severe disabling pain after
more than 6 months after surgery. Numerous other
studies report a pain prevalence of 28–56% from 3 to
28 months after CABG surgery [15–20]. Many
theories for its cause have been proposed in litera-
ture, but the aetiology is still not clear and no ther-
apy or technique has been shown to reduce chronic
pain after CABG surgery [17, 21]. In literature this
syndrome is described as chronic chest pain [19],
chronic thoracic pain [18], chronic post-sternotomy
pain [14–20].
Chronic pain after CABG surgery is a major clinical
problem, which is distressing and reduces the quality of
life of patients [14].
As a result, many patients undergoing CABG surgery
suffer from decreased pulmonary function, reduced thor-
acic mobility and/or chronic thoracic pain. These anom-
alies have significant clinical repercussion and may have
an effect on the patients’ quality of life [14].
According to current clinical guidelines, exercise
intervention should be initiated early after CABG sur-
gery [22]. According to these recommendations, exer-
cise training should be individually tailored according
to the clinical condition, baseline exercise capacity
and ventricular function. Upper-body training can
begin when the sternal wound is stable. The general
applicable exercise training in cardiac rehabilitation
consists of walking, jogging, cycling, swimming, row-
ing, stair climbing, elliptical trainers and aerobic dan-
cing, at low to moderate exercise intensity, for 3–5
days/week. Programmes should last up to 12 weeks
for outpatient settings. However in this trajectory,
pulmonary function, thoracic pain and thoracic mobil-
ity are not specifically targeted.
In fact, to our knowledge there are no effective treat-
ments to treat the latter conditions or effective prevent-
ive interventions. Osteopathic treatment (OT) has been
used to treat and manage pain symptoms. Several arti-
cles have been published addressing acute and chronic
pain in different medical conditions [23–25]. However,
no trials have been conducted to test the effect of OT
on chronic pain after CABG surgery.
Methods/Design
Aim of the study
The aim of this randomised controlled trial is to exam-
ine whether OT could lead to a better treatment of
chronic thoracic pain, decreased pulmonary function
and/or decreased thoracic mobility.
We hypothesized that OT reduces the decrease in
SVC, reduces chronic thoracic pain, reduces thoracic
stiffness and improves the quality of life in patients at
12 weeks and 52 weeks after CABG surgery.
Design
OstinCaRe stands for Osteopathy in Cardiac Rehabilita-
tion. The OstinCare-study is designed as a randomised
controlled trial with two parallel groups. Group A will
receive a standard exercise-based cardiac rehabilitation
programme and group B will receive a standard
exercise-based cardiac rehabilitation programme with
four additional osteopathic treatments. The study will be
performed at the Jessa Hospital Hasselt, Belgium.
Roncada BMC Complementary and Alternative Medicine  (2016) 16:482 Page 2 of 9
Participants
Subjects admitted to the hospital for elective CABG with
median sternotomy will be eligible for this study. Partici-
pant recruitment began in January 2010 and is expected
to finish in December 2017. Subjects with diagnosed
chronic obstructive pulmonary disease, diagnosed neuro-
logic disease that prevents participation in the cardiac
rehabilitation programme, diagnosed nephrological dis-
ease that requires haemodialysis, prior thoracic surgery,
surgery in the epigastric, right or left hypochondriac re-
gion will be excluded. Subjects will also be excluded if
the subject has a prolonged stay (>5 days) in the inten-
sive care unit. All CABG surgery procedures will be per-
formed by the same surgical team. Subjects may not
receive any other manual treatment on the spine and/or
thorax during the study.
Randomisation and masking
Patients will be randomly assigned in a 1:1 ratio to either
group A or group B (Fig. 1). A blocked allocation sched-
ule will be used. Randomisation will be performed by
means of opaque, sealed envelopes. A physical therapist
of the cardiac rehabilitation centre will perform and
store the randomisation. The personnel of the cardiac
rehabilitation centre performing the outcome measure-
ments in this study are unaware of patient’s allocation.
Osteopathic treatments will not be performed in the
presence of the personnel of the cardiac rehabilitation
centre. The treatments will be performed in another lo-
cation to assure that the personnel of the cardiac re-
habilitation centre remains blinded to patient’s
allocation. Only the treating osteopaths will be aware of
the patient’s allocation. The enrolment and procedures
are visualised in Fig. 2 according to the Standard Proto-
col Items: Recommendations for Interventional Trials
(SPIRIT) guidelines [26, 27].
Intervention
Cardiac rehabilitation programme
The cardiac rehabilitation programme is a multidisciplin-
ary programme in line with the current guidelines. Com-
ponents of the multidisciplinary programme include
patient assessment, physical activity counselling, exercise
training, diet/nutritional counselling, weight control man-
agement, lipid management, blood pressure monitoring,
smoking cessation, and psychosocial management [22].
The outpatient exercise-based cardiac rehabilitation
programme includes endurance training. No strength
training exercises are executed. According to cardiac
rehabilitation literature, all patients exercise under
close supervision 3 days per week for a total duration
of 3 months [28], and because this frequency is easily
attainable for most patients. Exercise training intensity
is determined by baseline Vo2peak assessment [29].
Fig. 1 Flow of participants during the conduct of the trial
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Patients exercise at a heart rate corresponding to 65%
of baseline Vo2peak. Each exercise training session
takes 45 min. Exercise time is apportioned as follows:
42% on the cycle ergometer, 33% on the treadmill
and 25% on the arm-cranking device [30].
Osteopathic procedure
The protocol used for OT and osteopathic examin-
ation (OE) incorporates a number of osteopathic
techniques and will be performed by five registered
osteopaths with a minimum experience of 5 years.
The protocol used is based on the work of Dickey
[31] and supplemented with the findings of other au-
thors [32–35]. The most common findings found in
literature are:
 Decrease in costal mobility [8, 10, 11, 36]
 Decrease in pulmonary function [6, 8, 10]
 Decreased thoracic mobility [8, 10, 11, 31]
 Dysfunction of the abdominal diaphragm [31, 37–41]
The nomenclature, indications and contraindications
for the OE and OT are based on the work of Nicholas
and Nicholas [32], Chila [42], on the professional com-
petence profile of an osteopath [43–45] and the bench-
marks of the World Health Organisation [46].
The OE protocol is a set of standardised test for a first
evaluation of the patient. The findings are noted on a
predefined Microsoft excel-file by the Osteopath.
 Inspection: in standing, seated and supine: observe
the patient in posterior, anterior and lateral view to
develop the most complete understanding of the
patients makeup before performing the remainder of
the OE ([32] p. 3–14).
 Position test of the thoracic spine (seated) ([42]
p.561)
 Intersegmental motion testing:
 thoracic seated ([32] p. 42–49)
 cervical supine ([32] p. 60–65)
 costal supine ([32] p. 52–59
Fig. 2 Study content for the schedule of enrolment, interventions, and assessments. -t2: preoperative, -t1: 9
th postoperative day, t0: start of
cardiac rehabilitation programme (3 weeks postoperative), t1: 4 weeks postoperative, t2: 5 weeks postoperative, t3: 9 weeks postoperative,
t4: 12 weeks postoperative, t5: 12 months postoperative. SVC: slow vital capacity. VAS: visual analogue scale. MacNew QLQ: MacNew
quality of life questionnaire
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 Costal motion testing supine [32] (p.53–56)
 Evaluation of the abdominal diaphragm (seated and
supine) ([42] p. 567)
The OT consists of a standardised treatment protocol
(Table 1) and a supplementary treatment protocol of the
dysfunctions found during the examination. In order to
be reproducible, the different treatment possibilities are
discussed and presented (Fig. 3). The OT will take 30–
45 min. The examination room is air-conditioned and
has a constant temperature of 21–22 °C. The OT will be
performed at 4 weeks postoperative (t1), 5 weeks postop-
erative (t2), 9 weeks postoperative (t3) and at 12 weeks
postoperative (t4). OT can be considered as safe, and
major adverse events are very rare [47, 48]. In case ad-
verse events should occur, they will be recorded and dis-
cussed in the final paper.
Outcome measures
Primary outcome measure will be the mean difference in
change from baseline in SVC at 12 weeks after surgery
between the two groups.
Secondary outcome measures will include:
 Change from baseline in SVC at 52 weeks
 Change from baseline in MacNew QLQ at 12 and
52 weeks after surgery
 Change in pain from baseline on Visual Analogue
Scale (VAS) at 12 and 52 weeks after surgery
 Change in thoracic stiffness from baseline on VAS at
12 and 52 weeks after surgery
 Change from baseline in maximal aerobic capacity
(VO2max) at 12 weeks after surgery
Spirometry
The Pocket-Spiro USB100 (Medical Electronic Construc-
tion & Logistic nv, Belgium) will be used for measuring
pulmonary function. All patients are asked to perform a
slow vital capacity (SVC) test, consisting of three mea-
surements. For VC the best of the three measurements
is used and for IVC the average of three measurements
is used [49]. The instrument is calibrated prior to the
test. When an OT is planned, SVC will be measured at
least 2 days after OT, because the study wants to meas-
ure long-term effects (effects of the entire intervention),
instead of any short-term effect (within the first hours
after OT). SVC will be measured preoperative (-t2), 9
th
postoperative day (-t1), 4 weeks after surgery (t1), 8 weeks
after surgery (t3), 12 weeks after surgery (t4) and at
12 months after surgery (t5).
Ergospirometry
All patients will perform a maximal cardiopulmonary ex-
ercise test on a cycle ergometer [50]. All the exercise
Table 1 Standard treatment protocol OstinCaRe study
Osteopathic technique Description Rationale for use
Doming/stretching of the
abdominal diaphragm [31–33]
Direct release of the respiratory diaphragm: the
patient is supine and the osteopath stands on
the homolateral side of the patient. The
osteopath places the cubital side of the
heterolateral hand under the anterior costal
margin and the fingers of the homolateral
hand under the posterior costal margin.
During inspiration, the hands follow the
expansion of the ribs and during expiration,
the osteopath holds the expansion of the
ribs. This is repeated 3–4 times on each side.
Improves motion of diaphragm
Releases connective tissue
tension within structures of the thorax
Myofascial release of the
thorax [33]
One hand is placed posterior on one hemi
thorax, the other hand anterior of the same
hemi thorax (according to the anatomy of
the ribs). Determine the direction of free
movement with passive motion testing.
Maintain either indirect or direct position
until release. The osteopath stimulates the






Suboccipital inhibition [31, 33, 34] Fingertips are placed on occipital condyles.
The osteopath applies an outward and
cephalad traction to decompress the
occipital joint
Improves parasympathetic function
Releases restricted tissues around
vagus nerves
Equilibration anterior-posterior [35] One hand is placed under the sacrum and
one hand on the sternum. The osteopath
follows and synchronizes the expression of
the primary respiration between sacrum
and sternum. The same is done between
the occiput and the sternum.
Improves lymphatic and venous
circulation
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tests will be performed at the same time of day (between
8.30 and 11.30 am). The test will be performed at
4 weeks after surgery (t1), 9 weeks after surgery (t3) and
at 12 weeks after surgery (t4).
During the exercise test, an electronically braked e-
Bike (Acertys) is used. The cycling frequency is set at
70 cycles/min. In addition, exercise tests will be prema-
turely ended when myocardial ischemia and/or severe
ventricular arrhythmias would occur and the subject will
be excluded from the study. Both the starting and incre-
mental cycling resistance will be set between 10 and
40 W and increased every minute to volitional fatigue.
Pulmonary gas exchange analysis will be performed by
using cardiopulmonary ergospirometry device (Jaeger
MasterScreen CPX). Before every test, a gas and volume
calibration will be executed. During the test, environ-
mental temperature is kept stable (19–21 °C). Oxygen
uptake, expiratory volume and respiratory exchange ratio
are collected breath-by-breath and averaged every 10 s.
Using a 12-lead ECG device, heart rate is monitored and
averaged every 10 s. In addition, maximal cycling resist-
ance and total test duration are reported. By V-slope
method, ventilatory threshold is calculated. The criteria
for defining a maximal cardiopulmonary exercise test
are an achieved heart rate > 85% of the maximal
predicted heart rate, and/or a Respiratory gas Exchange
Ratio (RER) > 1,09 [51].
MacNew quality of life questionnaire (QLQ) and Visual
analogue scale (VAS)
The Flemish version of the MacNew QLQ and the VAS
for pain and thoracic stiffness are delivered to the pa-
tients by a blinded person of the cardiac rehabilitation
centre at enrolment (t0), 12 weeks after surgery (t4) and
at 12 months after surgery (t5). The Flemish version of
the MacNew QLQ demonstrates good psychometric
properties and is recommended as a specific instrument
for assessing and evaluate health-related quality of life in
Flemish-speaking patients [52].
Data management
All procedures comply with confidentiality standards for
medical data. Authorized medical staff treating the pa-
tient is granted unconstrained access to the patients’
data, whereas restricted access to anonymized data is
granted to other local staff and researchers. All data will
be entered electronically and all original forms will be
kept at the study site. Participant files are stored in al-
phabetical order and stored in a secure and accessible
place and manner at the study site. Participant files will
Fig. 3 Supplementary osteopathic treatment protocol. Abbreviations: HVLA: high velocity low amplitude manipulation; MET: muscle energy technique
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be maintained in storage for a period of 3 years after
completion of the study. During this time, access to the
completely encrypted dataset can be obtained on indi-
vidual demand. A back-up of all data will be performed
every week on a USB-stick and on the hospitals’ backup
server. Because the known minimal risk of this study a
data monitoring committee is not needed [53]. Import-
ant protocol modifications during this study will be
communicated to the trial registry and the journal of
publication.
Sample size
A priori sample size calculation is based on pulmonary
function (by GPower 3.1). The hypothesis for the Ostin-
CaRe study is that the addition of OT towards endur-
ance exercise training increases inspiratory vital capacity
(IVC) by 12% during the follow-up of CABG patients.
Power analysis is based on a 12% decrease in IVC at
12 weeks after surgery [11]. As a result, an increase of
approximately 12% of the IVC is expected at 12 weeks
after CABG. Sample size is computed considering an ef-
fect size of 0.50, a statistical power of 0.80 and an alpha
level of 0.05. The power analysis outcome defines that
128 subjects per group are needed. Based on unpub-
lished data of the cardiac rehabilitation centre a dropout
rate of 20% is to be expected. Therefore, 154 subjects
per group are needed. Participant recruitment began in
January 2010 and is expected to finish in December
2017. Interim analysis is planned when 154 (50%) pa-
tients are included. The study can be stopped before
reaching sample size if there is a significant change in
surgery technique, which could compromise reproduci-
bility and comparability throughout the study. The au-
thor makes the final decision to terminate the trial.
Statistical analysis
Data will be analysed by a statistician blinded to group
allocations, using the Statistical Package for the Social
Sciences (SPSS) v. 22.0 (IBM). First, descriptive statistics
will be executed, with calculation of means and standard
deviations, and analysis of data distribution (by Shapiro-
Wilk test) and evaluation of outliers. In case of normal
data distribution, one-way ANOVA with repeated mea-
sures will be executed to analyse and compare changes
in parameters between groups (with Bonferroni correc-
tions for multiple comparisons). Relations between pa-
rameters will be examined by Pearson correlations. In
case of non-normal data distribution, absolute changes
in parameters will be compared between groups by
Mann Whitney U-tests (with Bonferroni corrections for
multiple comparisons). Relations between parameters
will be examined by Spearman correlations. Statistical
significance is set at p < 0.05, two-tailed. Observed statis-
tical power will be calculated by use of GPower v. 3.1.
Intention to treat analysis will be executed. Missing data
will be handled using the last observation carried for-
ward imputation technique. Dropouts and withdrawals
from the study will be recorded through the intervention
and follow-up periods. When differences in baseline
phenotype are present, these differences will be taken
into account during analysis of treatment effect between
groups, by regarding them as co-variates.
Discussion
Although CABG surgery is an effective coronary
revascularisation technique, there are a number of
postoperative complications, such as diminished pul-
monary function and chronic thoracic pain, from
which patients are prone to suffer from [10, 11, 14–20].
To our knowledge, there are no effective treatments to
treat these conditions or effective preventive interventions
[6, 17, 21]. The OstinCaRe study has been designed to ex-
plore the potential long-term added value of OT in the
management of decreased pulmonary function, chronic
thoracic pain and diminished thoracic mobility after
CABG surgery. The present study is the first study to
examine long-term effects of OT after CABG surgery
using rigorous procedures and gold standard methods for
clinical trials. Previous studies studied the short-term ef-
fects of OT after CABG surgery. One study has proven
that OT has immediate, beneficial haemodynamic effects
after CABG surgery when administered while the patient
is sedated [34]. Another study mentioned beneficial,
though statistically insignificant, effect of OT on length of
stay and recovery of bowel function of CABG surgical
patients [54].
The expected outcomes from the present study will be
increased pulmonary function, reduction in thoracic
pain and increased thoracic mobility. The study has the
potential to deliver the first valuable complement in
cardiac rehabilitation programmes to address these
problems.
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